Biotech Boom: Stocks Surge on New Drug Approvals
Wall Street is buzzing with excitement as biotech stocks soar in response to a wave of newly approved drug authorizations. Investors are pouring money into the sector, driven by the promise of these transformative therapies that address complex diseases. The biotech industry is on the cusp of a monumental leap forward, and investors are eager to be